verapamil has been researched along with Sclerosis, Systemic in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertrophic cardiomyopathy is associated with the human lymphocyte antigen (HLA DR3), and this may provide a possible link with SSc, as this HLA phenotype is common in the latter condition." | 1.33 | Hypertrophic cardiomyopathy in systemic sclerosis. A report of two cases. ( Anastasiadis, G; Moyssakis, I; Papadopoulos, DP; Vlachoyannopoulos, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moyssakis, I | 1 |
| Papadopoulos, DP | 1 |
| Anastasiadis, G | 1 |
| Vlachoyannopoulos, P | 1 |
| Ackerman, Z | 1 |
| Lysy, J | 1 |
| Meiner-Lavie, V | 1 |
| O'Brien, JT | 1 |
| Hill, JA | 1 |
| Pepine, CJ | 1 |
| Sowemimo-Coker, SO | 1 |
| Kovacs, IB | 1 |
| Kirby, JD | 1 |
| Turner, P | 1 |
4 other studies available for verapamil and Sclerosis, Systemic
| Article | Year |
|---|---|
Hypertrophic cardiomyopathy in systemic sclerosis. A report of two cases.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart Septum; | 2006 |
The association of fecal impaction and verapamil in a patient with scleroderma.
Topics: Adult; Constipation; Fecal Impaction; Female; Humans; Raynaud Disease; Scleroderma, Systemic; Verapa | 1989 |
Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis.
Topics: Female; Humans; Hypertension, Pulmonary; Middle Aged; Scleroderma, Systemic; Verapamil | 1985 |
Effects of verapamil on calcium-induced rigidity and on filterability of red blood cells from healthy volunteers and patients with progressive systemic sclerosis.
Topics: Adult; Aged; Calcium; Dose-Response Relationship, Drug; Erythrocyte Deformability; Humans; Middle Ag | 1985 |